08Feb 2021
Clinical utility of targeted next generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

Clinical utility of targeted next generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

Myeloid neoplasms with germline predisposition (MNGP) are likely to be more common than currently appreciated. Many of the genes involved in MNGP are also recurrently mutated in sporadic myeloid neoplasms (MN). Therefore, routine analysis of gene panels by NGS provides an effective approach to detect germline variants with clinical significance in patients with hematological malignancies.

  • #oncology

Like

Save

Share